Prominent Staining of MYCN Immunohistochemistry Predicts a Poor Prognosis in MYCN Non-Amplified Neuroblastoma
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric and Developmental Pathology"
DOI: 10.1177/10935266231151316
Abstract: Background: MYCN gene amplification is a powerful indicator of poor prognosis of neuroblastoma patients. However, MYCN non-amplified patients still showed heterogeneity in survival outcome. This study aimed to investigate the prognostic role of MYCN immunohistochemistry… read more here.
Keywords: amplification; poor prognosis; staining mycn; mycn ... See more keywords